NCT00208962View on ClinicalTrials.gov

Allogeneic Cell Therapy for Adults With Hematologic Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

September 30, 2007

Study Completion Date

August 31, 2013

Conditions
Hematologic Diseases
Interventions
PROCEDURE

chemotherapy and blood stem cell transplantation

A combination of conventional dose chemotherapy, granulocyte-colony stimulating factor (G-CSF) mobilized HLA-identical related allogeneic PBSC transplant, and post transplant infusions of donor leukocytes.

Trial Locations (1)

30322

Emory University Winship Cancer Institute, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT00208962 - Allogeneic Cell Therapy for Adults With Hematologic Malignancies | Biotech Hunter | Biotech Hunter